PGR and neoplasm: It is a highly heterogeneous tumor that is clinically classified into four distinct subtypes 2, based on the expression patterns of immunohistochemical markers, including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and KI-67.